Immunotherapy is a powerful weapon in the fight against cancer, but inflammation of the heart muscle (myocarditis) is one of its most serious side effects. This has been highlighted in a review article on the immunological ...
Apr 16, 2020
0
2
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of the cancer, according to results of a clinical trial led by Mount Sinai researchers ...
Apr 9, 2020
0
4
Patients with colon cancer but without distant metastases can benefit from a short course of immunotherapy while waiting for their surgery, as it can cause tumours to shrink substantially or clear up in a very short time. ...
Apr 6, 2020
0
87
Thyroid dysfunction following cancer treatment with new treatments called immune checkpoint inhibitors is more common than previously thought, according to research that was accepted for presentation at ENDO 2020, the Endocrine ...
Mar 31, 2020
0
1
Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded. The reservoir includes ...
Mar 16, 2020
0
74
Tumors have figured out various ways to prevent the immune system from attacking them. Medicine, for its part, has fought back with cancer immunotherapies. The major approach uses checkpoint inhibitors, drugs that help the ...
Mar 11, 2020
0
114
Could the response to cancer immunotherapy depend on bacteria that originate in the gut and travel to the tumor?
Mar 6, 2020
0
518
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug—originally developed to tackle the scarring of organ tissue—could help to significantly improve the success rate of cancer ...
Mar 2, 2020
0
101
A team of researchers affiliated with multiple institutions in Italy has found that giving cancerous mice high doses of vitamin C (ascorbic acid) enhanced immunotherapy, resulting in slowed or stopped tumor growth. In their ...
An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.
Feb 26, 2020
0
19
